Log In
Print
BCIQ
Print
Print this Print this
 

Reolysin

  Manage Alerts
Collapse Summary General Information
Company Oncolytics Biotech Inc.
DescriptionFormulation of human reovirus type 3
Molecular Target Not applicable
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today